Oncology testing in general practice

In a preview of his lecture later today at Fetch Kanas City in Missouri, Craig A Clifford DVM, MS, DACVIM (Oncology), explains how the BRAF test can be used by general practitioners at their hospitals to potentially provide early detection for cancers through urine testing to detect abnormalities from urethral carcinoma.

Fetch Kansas City kicks off today, but there is still time to sign up! You can learn more and register here today. Also, if you are at the Kansas City Convention Center and see Clifford, be sure to wish him a belated happy birthday!

Below is a partial transcript

Craig A Clifford DVM, MS, DACVIM (Oncology): One of the ones that i tend to push for is something called the BRAF test. Basically, we know is that bladder cancer in dogs is called transitional cell carcinoma or we are moving toward the term called urethral carcinoma to match that in people. Some pretty smart people at North Carolina and NIH figured out that 85% to 95% of the urethral carcinomas have a mutation inside of them and, just like on our skin, our cells are shed into the air. When the badder loses cells, they are shed into the urine. Basically, the test looks at the cells that are shed into the urine and 'do you have this abnormality?'